Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Delphine Desigaud"'
Autor:
Renaud Cezar, Delphine Desigaud, Manuela Pastore, Lucy Kundura, Anne-Marie Dupuy, Chantal Cognot, Thierry Vincent, Christelle Reynes, Robert Sabatier, Elisabeth Maggia, Pierre Corbeau
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract We tested the hypothesis that a particular immune activation profile might be correlated with insulin resistance in a general population. By measuring 43 markers of immune, endothelial, and coagulation activation, we have previously shown th
Externí odkaz:
https://doaj.org/article/17d11f43d3ac4fe0b67d3fe5b6818b6f
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Oxaliplatin combined with the ATR inhibitor VE-822 induces immune death signalling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1967a627961a165c7e604fc22df7e2d
https://doi.org/10.1158/0008-5472.22420949
https://doi.org/10.1158/0008-5472.22420949
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Although many patients with colorectal cancer initially respond to the chemotherapeutic agent oxaliplatin, acquired resistance to this treatment remains a major challenge to the long-term management of this disease. To identify molecular targets of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc9ed29041f254d948ae7a38444cd60
https://doi.org/10.1158/0008-5472.c.6510791.v1
https://doi.org/10.1158/0008-5472.c.6510791.v1
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Effect of ATR inhibition combined with oxaliplatin treatment on the ATR and ATM pathways.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7fab0aebbf41895d5bdd5b30bd5bf75
https://doi.org/10.1158/0008-5472.22420955.v1
https://doi.org/10.1158/0008-5472.22420955.v1
Autor:
Celine Gongora, Nadia Vezzio-Vie, Roderick L. Beijersbergen, Maguy Del Rio, Pierre Martineau, Jerome Moreaux, Nathalie Bonnefoy, Philippe Pasero, Arnaud Coquelle, Marta Jarlier, Delphine Desigaud, Veronique Garambois, Flavie Coquel, Henri-Alexandre Michaud, Diego Tosi, Augusto F. Andrade, Eve Combès
Molecular characteriistics of cell lines used in the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b28f2922d527d97c5cc1aebba6cac9
https://doi.org/10.1158/0008-5472.22420946.v1
https://doi.org/10.1158/0008-5472.22420946.v1
Autor:
Manuela Pastore, Pierre Corbeau, Anne-Marie Dupuy, Chantal Cognot, Elisabeth Maggia, Christelle Reynes, Delphine Desigaud, Renaud Cezar, Robert Sabatier, Lucy Kundura, Thierry Vincent
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.12314. ⟨10.1038/s41598-021-91758-3⟩
Scientific Reports, 2021, 11 (1), pp.12314. ⟨10.1038/s41598-021-91758-3⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.12314. ⟨10.1038/s41598-021-91758-3⟩
Scientific Reports, 2021, 11 (1), pp.12314. ⟨10.1038/s41598-021-91758-3⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
We tested the hypothesis that a particular immune activation profile might be correlated with insulin resistance in a general population. By measuring 43 markers of immune, endothelial, and coagulation activation, we have previously shown that five d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171e9d01f1c6cd3667365a3891f1c61e
https://hal.archives-ouvertes.fr/hal-03263947
https://hal.archives-ouvertes.fr/hal-03263947
Autor:
Audrey Winter, Robert Sabatier, Lucy Kundura, Renaud Cezar, Christelle Reynes, Delphine Desigaud, Jean-Philippe Lavigne, Elisabeth Maggia, Chantal Cognot, Anne-Marie Dupuy, Patricia Le Merre, Thierry Vincent, Manuela Pastore, Catherine Dunyach-Remy, Pierre Corbeau
Publikováno v:
Scientific Reports
Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-77707-6⟩
Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-77707-6⟩
Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-77707-6⟩
Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-77707-6⟩
Latent infectious agents, microbial translocation, some metabolites and immune cell subpopulations, as well as senescence modulate the level and quality of activation of our immune system. Here, we tested whether various in vivo immune activation pro
Autor:
Maguy Del Rio, Nathalie Bonnefoy, Nadia Vezzio-Vie, D. Tosi, Arnaud Coquelle, Flavie Coquel, Jérôme Moreaux, Marta Jarlier, Delphine Desigaud, Roderick L. Beijersbergen, Céline Gongora, Augusto Faria Andrade, Pierre Martineau, Philippe Pasero, Eve Combes, Henri-Alexandre Michaud, Véronique Garambois
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2019, 79 (11), pp.2933-2946. ⟨10.1158/0008-5472.CAN-18-2807⟩
Cancer Research, American Association for Cancer Research, 2019, 79 (11), pp.2933-2946. ⟨10.1158/0008-5472.CAN-18-2807⟩
Although many patients with colorectal cancer initially respond to the chemotherapeutic agent oxaliplatin, acquired resistance to this treatment remains a major challenge to the long-term management of this disease. To identify molecular targets of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eec7a4447f79e063a2db278b28005f3
https://hal.archives-ouvertes.fr/hal-02361669
https://hal.archives-ouvertes.fr/hal-02361669
Autor:
Eve, Combès, Augusto F, Andrade, Diego, Tosi, Henri-Alexandre, Michaud, Flavie, Coquel, Veronique, Garambois, Delphine, Desigaud, Marta, Jarlier, Arnaud, Coquelle, Philippe, Pasero, Nathalie, Bonnefoy, Jerome, Moreaux, Pierre, Martineau, Maguy, Del Rio, Roderick L, Beijersbergen, Nadia, Vezzio-Vie, Celine, Gongora
Publikováno v:
Cancer research. 79(11)
Although many patients with colorectal cancer initially respond to the chemotherapeutic agent oxaliplatin, acquired resistance to this treatment remains a major challenge to the long-term management of this disease. To identify molecular targets of o
Autor:
Vincent Denis, Christel Larbouret, Laetitia K. Linares, Esther Pérez-Gracia, Delphine Desigaud, Adeline Ayrolles-Torro, Nadia Vie, M. del Rio, Marta Jarlier, Clara Montagut, Diego Tosi, E W-F Lam, Laetitia Marzi, Mar Iglesias, Céline Gongora, Pierre Martineau, Eve Combes
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2016, 115 (10), pp.1223-1233. ⟨10.1038/bjc.2016.313⟩
British Journal of Cancer, Cancer Research UK, 2016, 115 (10), pp.1223-1233. ⟨10.1038/bjc.2016.313⟩
BACKGROUND: Cetuximab, a monoclonal antibody against EGFR used for the treatment of colorectal cancer (CRC), is ineffective in many patients. The aim of this study was to identify the signalling pathways activated by cetuximab in CRC cells and define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4579077d1c4aa1c4faf7dd0c8990a4d2
https://www.hal.inserm.fr/inserm-02465222
https://www.hal.inserm.fr/inserm-02465222